İsmail Hanta

749 total citations
46 papers, 360 citations indexed

About

İsmail Hanta is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Physiology. According to data from OpenAlex, İsmail Hanta has authored 46 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 10 papers in Physiology. Recurrent topics in İsmail Hanta's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). İsmail Hanta is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). İsmail Hanta collaborates with scholars based in Türkiye and Kuwait. İsmail Hanta's co-authors include Ali Kocabaş, Gülşah Şeydaoğlu, Süleyman Özbek, Handan Zeren, Can Sevinç, Aykut Çilli, A. İskender Göçer, Tahsin Erman, Suzan Zorludemir and Cem Kaan Parsak and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Cardiology and World Journal of Surgery.

In The Last Decade

İsmail Hanta

43 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İsmail Hanta Türkiye 12 151 127 95 74 67 46 360
Adelina Yafasova Denmark 10 85 0.6× 45 0.4× 65 0.7× 48 0.6× 66 1.0× 33 351
Yoshiyuki Fujii Japan 11 106 0.7× 78 0.6× 34 0.4× 26 0.4× 91 1.4× 35 352
M Ashour Saudi Arabia 15 232 1.5× 246 1.9× 70 0.7× 47 0.6× 34 0.5× 39 575
Nikolaos Kolaitis Greece 12 75 0.5× 84 0.7× 99 1.0× 13 0.2× 20 0.3× 31 405
Nataša Marković Serbia 11 69 0.5× 78 0.6× 66 0.7× 27 0.4× 11 0.2× 56 415
Kang Kim South Korea 10 177 1.2× 72 0.6× 88 0.9× 67 0.9× 70 1.0× 21 382
Ayhan Dağdemir Türkiye 13 77 0.5× 80 0.6× 49 0.5× 24 0.3× 23 0.3× 48 386
Marek Krawczyk Poland 7 168 1.1× 300 2.4× 92 1.0× 13 0.2× 60 0.9× 41 474
Mariia Chibireva Italy 7 88 0.6× 33 0.3× 38 0.4× 61 0.8× 38 0.6× 12 249

Countries citing papers authored by İsmail Hanta

Since Specialization
Citations

This map shows the geographic impact of İsmail Hanta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İsmail Hanta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İsmail Hanta more than expected).

Fields of papers citing papers by İsmail Hanta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İsmail Hanta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İsmail Hanta. The network helps show where İsmail Hanta may publish in the future.

Co-authorship network of co-authors of İsmail Hanta

This figure shows the co-authorship network connecting the top 25 collaborators of İsmail Hanta. A scholar is included among the top collaborators of İsmail Hanta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İsmail Hanta. İsmail Hanta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Arslan, Didem, et al.. (2024). Sleep Disturbance in Systemic Sclerosis and the Associations Between Sleep and Pulmonary Hypertension: A Pilot Study. SHILAP Revista de lepidopterología. 11(1). 45–51. 1 indexed citations
4.
Arslan, Didem, et al.. (2023). Microvascular damage evaluation based on nailfold videocapillarosopy in sarcoidosis. Clinical Rheumatology. 42(7). 1951–1957. 3 indexed citations
5.
Hanta, İsmail, et al.. (2023). The Effect of Vaccination on Biochemical and Inflammatory Markers in Hospitalized COVID-19 Patients. Kafkas Journal of Medical Sciences. 13(2). 155–159. 1 indexed citations
6.
Çilli, Aykut, İsmail Hanta, Funda Çoşkun, et al.. (2022). Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study. Respiratory Medicine and Research. 81. 100900–100900. 11 indexed citations
7.
Saygıdeğer, Yasemin, Aslıhan Candevir, Süheyla Kömür, et al.. (2021). COVID-19 patients’ sera induce epithelial mesenchymal transition in cancer cells. Cancer Treatment and Research Communications. 28. 100406–100406. 9 indexed citations
8.
Hanta, İsmail, Bahri Akdeniz, Sümeyye Güllülü, et al.. (2021). Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study. The Anatolian Journal of Cardiology. 25(10). 721–732. 1 indexed citations
9.
Deveci, Onur Sinan, et al.. (2020). Predictive value of plasma copeptin level for diagnosis and mortality of pulmonary embolism. Revista da Associação Médica Brasileira. 66(12). 1645–1650. 6 indexed citations
10.
Hanta, İsmail, Aykut Çilli, & Can Sevinç. (2019). The Effectiveness, Safety, and Tolerability of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Retrospective Study. Advances in Therapy. 36(5). 1126–1131. 18 indexed citations
11.
Özyılmaz, Ezgi, et al.. (2012). Endobronchial capillary hemangioma: a very rare cause of massive hemoptysis. Tuberkuloz ve Toraks. 60(1). 78–80. 2 indexed citations
12.
Hanta, İsmail, et al.. (2012). Association of the Nramp1 gene polymorphisms and clinical forms in patients with tuberculosis. Bratislavské lekárske listy/Bratislava medical journal. 113(11). 657–660. 4 indexed citations
13.
Ece, Ferah, et al.. (2009). Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Nonsmall Cell Lung Cancer. American Journal of Clinical Oncology. 32(3). 280–285. 2 indexed citations
14.
Parsak, Cem Kaan, İsmail Hanta, Ahmet Aslan, & Ömer Alabaz. (2008). Isolated Hepatic Tuberculosis Presenting as Cystic-Like and Tumour-Like Mass Lesions. Case Reports in Gastroenterology. 2(1). 18–21. 5 indexed citations
15.
Hanta, İsmail, et al.. (2008). The effect of different treatment modalities on oxidative stress in COPD. Advances in Therapy. 25(7). 710–717. 13 indexed citations
16.
Parsak, Cem Kaan, et al.. (2007). The Effectiveness of Nitric Oxide Derivates in Hydatid Disease. Visceral Medicine. 23(3). 296–299. 2 indexed citations
17.
Hanta, İsmail, et al.. (2007). Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFα. Clinical Rheumatology. 26(11). 1867–1870. 15 indexed citations
18.
Erman, Tahsin, et al.. (2005). Huge Bilateral Pulmonary and Pleural Metastasis from Intracranial Meningioma: A Case Report and Review of the Literature. Journal of Neuro-Oncology. 74(2). 179–181. 36 indexed citations
19.
Hanta, İsmail, et al.. (2003). The Oxidant-Antioxidant Balance in Mild Asthmatic Patients. Lung. 181(6). 347–352. 18 indexed citations
20.
Paydaş, Semra, Sinan Yavuz, Umut Dişel, et al.. (2002). Granulomatous reaction after chemotherapy for Hodgkin’s disease. Leukemia Research. 26(10). 967–970. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026